Alight, Inc. / Delaware
ALIT· Services· Fiscal year ends in December
No proxy on file names the CEO of Alight, Inc. / Delaware.
Executives6
See all- 1David D. GuilmetteFormer Chief Executive Officer and Vice ChairFY2025
- 2Donna G. DorseyChief Human Resources OfficerFY2025
- 3Jeremy J. HeatonFormer Chief Financial OfficerFY2025
- 4Deepika DuggiralaChief Technology OfficerFY2025
- 5David EssaryFormer Chief Strategy OfficerFY2025
- 6Allison P. BassiouniChief Delivery OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAlight, Inc. / Delaware paid its 6 named executives $21.9M in total in FY2025 (Dec).
| Name | |||
|---|---|---|---|
| David D. GuilmetteFormer Chief Executive Officer and Vice Chair | Not disclosed | ||
| Donna G. DorseyChief Human Resources Officer | Not disclosed | Not disclosed | |
| Jeremy J. HeatonFormer Chief Financial Officer | Not disclosed | ||
| Deepika DuggiralaChief Technology Officer | Not disclosed | Not disclosed | |
| David EssaryFormer Chief Strategy Officer | Not disclosed | Not disclosed | |
| Allison P. BassiouniChief Delivery Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers14
See allThe FY2025 (Dec) proxy of Alight, Inc. / Delaware names 14 peer companies for pay. Among Alight, Inc. / Delaware and these peers, CEO pay was 6th highest of 8 and total shareholder return was the lowest of 8.
6th highest of 8in Alight, Inc. / Delaware and its pay peers, FY2025 (Dec) by CEO pay:
8th highest of 8in Alight, Inc. / Delaware and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 27, 2026 | FY2025 |
| Annual report | 10-K | Feb 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 22, 2025 | FY2024 |
| Annual report | 10-K | Feb 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Jun 4, 2024 | FY2023 |
| Annual report | 10-K | Feb 29, 2024 | FY2023 |